Table 1.
Compound | Sequence 1 | Cα | Cβ1 |
---|---|---|---|
PKI5–24 | TTYADFIASGRTGRRNAIHD | n.d. 2 | n.d. 2 |
1 | βA-TTYADFIASGRTGRRNAIHD | 0.7 ± 0.1 | |
2 | βA-TTY*DFI*SGRTGRRNAIHD | 5.2 ± 0.3 | |
3 | PEG3-TTYADFIASGRTGRRNAIHD | 0.8 ± 0.1 | |
4 | PEG3-TTY*DFI*SGRTGRRNAIHD | 5.4 ± 0.9 | |
PKI1–24 | TDVETTYADFIASGRTGRRNAIHD | n.d. 2 | |
5 | βA-TDVETTYADFIASGRTGRRNAIHD | 0.4 ± 0.1 | 0.4 ± 0.1 |
6 | βA-TDV*TTY*DFIASGRTGRRNAIHD | 0.6 ± 0.1 | 0.8 ± 0.3 |
7 | PEG3-TDVETTYADFIASGRTGRRNAIHD | 0.5 ± 0.1 | 0.5 ± 0.1 |
8 | PEG3-TDV*TTY*DFIASGRTGRRNAIHD | 0.7 ± 0.2 | 0.9 ± 0.3 |
1 Stars represent positions where 2-(4′-pentenyl) alanine was inserted into the sequence. 2 n.d.–not determined.